Prof. Dr. Douglas K. Graham received his Medical Degree and
his PhD in Microbiology and Immunology from the University of North Carolina in
Chapel Hill, NC. He completed his residency in pediatrics and a fellowship in
pediatric hematology/oncology at the University of Colorado. He is the chief of
the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of
Atlanta. He also serves as chief of the Division of Pediatric
Hematology/Oncology/BMT. Board-certified in pediatric hematology/oncology, his
clinical focus is in pediatric leukemia. At the same time, he is a National
Institutes of Health-funded investigator with an active laboratory focusing on
developing novel therapeutics for pediatric cancer, recently validating MerTK
as a novel cancer agent in leukemia, melanoma, non-small cell lung cancer, and
glioblastoma. He was the co-program leader of the Hematologic Malignancy
Program at the University of Colorado, a National Cancer Institute-designated
cancer center. Moreover, he is a member of the Children's Oncology Group, COG
Acute Myeloid Leukemia Disease Committee, and the NIH Molecular and Cellular
Hematology Study Section. He also holds memberships with the American Society
of Pediatric Hematology/Oncology, American Society of Hematology, American
Society for Cancer Research, American Society for Clinical Investigation,
Society for Pediatric Research, and American Academy of Pediatrics.
